Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).

P Reichardt; Dimosthenis Andreou; A Florcken; T Gross; S Richter; T Kessler; M Kortum; CA Schmidt; B Kasper; E Wardelmann; A Benedict; D Sookthai; DW Mueller; D Pink

Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).

P Reichardt
, Dimosthenis Andreou
, A Florcken
, T Gross
, S Richter
, T Kessler
, M Kortum
, CA Schmidt
, B Kasper
, E Wardelmann
, A Benedict
, D Sookthai
, DW Mueller
, D Pink

Department of Orthopaedics and Trauma

Research output: Contribution to journal › Conference abstract

4 Citations (Web of Science)

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	41
Issue number	16
Publication status	Published - 1 Jun 2023
Event	59th Annual Meeting of the American Society of Clinical Oncology - Chicago, United States Duration: 2 Jun 2023 → 6 Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

Links

Web of Science

Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).
Reichardt, P. (Author), Andreou, D. (Author), Florcken, A. (Author), Gross, T. (Author), Richter, S. (Author), Kessler, T. (Author), Kortum, M. (Author), Schmidt, C. (Author), Kasper, B. (Author), Wardelmann, E. (Author), Benedict, A. (Author), Sookthai, D. (Author), Mueller, D. (Author) & Pink, D. (Author)
2023
Activity: Talk, presentation or poster › Poster

Cite this

Reichardt, P., Andreou, D., Florcken, A., Gross, T., Richter, S., Kessler, T., Kortum, M., Schmidt, CA., Kasper, B., Wardelmann, E., Benedict, A., Sookthai, D., Mueller, DW., & Pink, D. (2023). Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc). Journal of Clinical Oncology, 41(16).

@article{33e9f14f71384a30b408819cb34f9a02,

title = "Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).",

author = "P Reichardt and Dimosthenis Andreou and A Florcken and T Gross and S Richter and T Kessler and M Kortum and CA Schmidt and B Kasper and E Wardelmann and A Benedict and D Sookthai and DW Mueller and D Pink",

year = "2023",

month = jun,

day = "1",

language = "English",

volume = "41",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "16",

note = "59th Annual Meeting of the American Society of Clinical Oncology, ASCO 59 ; Conference date: 02-06-2023 Through 06-06-2023",

}

Reichardt, P, Andreou, D, Florcken, A, Gross, T, Richter, S, Kessler, T, Kortum, M, Schmidt, CA, Kasper, B, Wardelmann, E, Benedict, A, Sookthai, D, Mueller, DW & Pink, D 2023, 'Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).', Journal of Clinical Oncology, vol. 41, no. 16.

Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc). / Reichardt, P; Andreou, Dimosthenis; Florcken, A et al.
In: Journal of Clinical Oncology, Vol. 41, No. 16, 01.06.2023.

Research output: Contribution to journal › Conference abstract

TY - JOUR

T1 - Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).

AU - Reichardt, P

AU - Andreou, Dimosthenis

AU - Florcken, A

AU - Gross, T

AU - Richter, S

AU - Kessler, T

AU - Kortum, M

AU - Schmidt, CA

AU - Kasper, B

AU - Wardelmann, E

AU - Benedict, A

AU - Sookthai, D

AU - Mueller, DW

AU - Pink, D

PY - 2023/6/1

Y1 - 2023/6/1

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001053772002805

M3 - Conference abstract

SN - 0732-183X

VL - 41

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

T2 - 59th Annual Meeting of the American Society of Clinical Oncology

Y2 - 2 June 2023 through 6 June 2023

ER -

Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).

UN SDGs

Branches of science

Links

Activities

Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).

Cite this